GENOMIC HEALTH INC Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 22.98 | 13,183 | 302,945 | 0 | |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 70.94 | 13,183 | 935,228 | 13,736 | 26.9 K to 13.7 K (-48.97 %) |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 22.98 | 13,183 | 302,945 | 26,919 | 13.7 K to 26.9 K (+95.97 %) |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Gift | G | 0.00 | 275 | 0 | 13,420 | 13.7 K to 13.4 K (-2.01 %) |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | M | 22.98 | 13,183 | 302,945 | 0 | |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 70.94 | 13,183 | 935,228 | 13,736 | 26.9 K to 13.7 K (-48.97 %) |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 22.98 | 13,183 | 302,945 | 26,919 | 13.7 K to 26.9 K (+95.97 %) |
| Oct 21 2019 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Gift | G | 0.00 | 275 | 0 | 13,420 | 13.7 K to 13.4 K (-2.01 %) |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 33.21 | 4,500 | 149,445 | 39,707 | |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 67.75 | 4,500 | 304,875 | 16,417 | 20.9 K to 16.4 K (-21.51 %) |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 33.21 | 4,500 | 149,445 | 20,917 | 16.4 K to 20.9 K (+27.41 %) |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 67.74 | 10,000 | 677,364 | 68,268 | 78.3 K to 68.3 K (-12.78 %) |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 30.84 | 22,560 | 695,750 | 20,000 | |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 69.01 | 22,560 | 1,556,886 | 38,970 | 61.5 K to 39 K (-36.67 %) |
| Oct 09 2019 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 30.84 | 22,560 | 695,750 | 61,530 | 39 K to 61.5 K (+57.89 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 67.28 | 185 | 12,447 | 7,833 | 7.6 K to 7.8 K (+2.42 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | Flannelly Barry P | Director | Grant | A | 67.28 | 185 | 12,447 | 397 | 212 to 397 (+87.26 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 67.28 | 185 | 12,447 | 69,120 | 68.9 K to 69.1 K (+0.27 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 67.28 | 185 | 12,447 | 53,304 | 53.1 K to 53.3 K (+0.35 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.28 | 370 | 24,894 | 7,642,042 | 7.6 M to 7.6 M (0.00 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.28 | 370 | 24,894 | 1,217,279 | 1.2 M to 1.2 M (+0.03 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.28 | 370 | 24,894 | 244,595 | 244.2 K to 244.6 K (+0.15 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.28 | 370 | 24,894 | 160,223 | 159.9 K to 160.2 K (+0.23 %) |
| Oct 03 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 67.28 | 370 | 24,894 | 165,980 | 165.6 K to 166 K (+0.22 %) |